Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Agomelatine is a new medication that, in conjunction with psychosocial counselling, appears to be effective at treating childhood depression.
Arango, C., Buitelaar, J. K., Fegert, J. M., Olivier, V., Pénélaud, P. F., Marx, U., … & Wolańczyk, T. (2021). Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries. The Lancet Psychiatry.
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00390-4/fulltext